logo

Sustained Release Excipients Market Share

Statistics for the 2023 & 2024 Sustained Release Excipients market share, created by Mordor Intelligence™ Industry Reports. Sustained Release Excipients share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Medical Consumables Research Laboratory Supplies Research Reagents and Solutions Research Sustained Release Excipients Market Market Share

Market Share of Sustained Release Excipients Industry

The global sustained release excipients market is competitive and consists of several major players. Mergers, acquisitions, collaborations for research and marketing, and the development of innovative products are some of the key strategies competitors are adopting to enhance their market share. Companies like Allergan PLC, AstraZeneca, GlaxoSmithKline PLC, Mayne Pharma Group Limited, Mylan NV, Novartis AG, Pfizer Inc., Salix Pharmaceuticals, and Sun Pharmaceutical Industries Ltd hold a substantial share in the market.

Sustained Release Excipients Market Leaders

  1. Mylan N.V.

  2. Pfizer, Inc.

  3. Sun Pharmaceutical Industries Ltd.

  4. Salix Pharmaceuticals

  5. Novartis AG

*Disclaimer: Major Players sorted in no particular order

3.png

Sustained Release Excipients Report Snapshots

Sustained Release Excipients Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)